CytomX Therapeutics (CTMX) Tax Rate Growth (5y) (2020 - 2025)

CytomX Therapeutics (CTMX) Tax Rate Growth (5y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn -
2 Nanobiotix 1,880.51 Bn 1,880.45 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 467.94 Bn 463.15 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.63 Bn 115.38 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.30 Bn 61.54 Bn 3.31 Bn
7 Belite Bio 62.81 Bn 62.81 Bn -
8 Argenx Se 55.78 Bn 50.59 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn
10 CytomX Therapeutics 598.30 Mn 251.59 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,434.00
Mar 31, 2025 -31,561.00
Dec 31, 2024 -25.00
Mar 31, 2024 31.00
Dec 31, 2023 9,430.00
Sep 30, 2023 6,049.00
Dec 31, 2020 -3.00